All Stories

  1. Removal of UK‐donor deferral for variant Creutzfeldt–Jakob disease: A large donation gain in Australia

    Article • Vox Sanguinis, August 2023, Wiley

    Doctor Clive R Seed

  2. Perceived risk of HIV transmission by blood transfusion among gay, bisexual, and other men who have sex with men (gbMSM) in Australia

    Article • Transfusion, June 2023, Wiley

    Doctor Clive R Seed

  3. Is dual testing for hepatitis C necessary? Modelling the risk of removing hepatitis C antibody testing for Australian blood donations

    Article • Vox Sanguinis, May 2023, Wiley

    Doctor Clive R Seed

  4. Removing hepatitis C antibody testing for Australian blood donations: A cost‐effectiveness analysis

    Article • Vox Sanguinis, May 2023, Wiley

    Doctor Clive R Seed

  5. Comment on White paper on pandemic preparedness in the blood supply

    Article • Vox Sanguinis, March 2023, Wiley

    Doctor Clive R Seed

  6. West Nile virus transfusion‐transmission risk in Australia associated with a seasonal outbreak in the United States

    Article • Transfusion, September 2022, Wiley

    Doctor Clive R Seed

  7. An Outbreak of Japanese Encephalitis Virus in Australia; What Is the Risk to Blood Safety?

    Article • Viruses, August 2022, MDPI AG

    Doctor Clive R Seed

  8. Risk of variant Creutzfeldt–Jakob disease transmission by blood transfusion in Australia

    Article • Vox Sanguinis, May 2022, Wiley

    Doctor Clive R Seed

  9. Severe Acute Respiratory Syndrome Coronavirus 2 and Blood Safety: An Updated Review

    Article • Transfusion Medicine and Hemotherapy, March 2022, Karger Publishers

    Doctor Clive R Seed

  10. Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review

    Article • Vox Sanguinis, December 2021, Wiley

    Doctor Clive R Seed

  11. HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men

    Article • Vox Sanguinis, July 2021, Wiley

    Doctor Clive R Seed

  12. Themed issue – focusing on donor assessment, motivation and vigilance

    Article • Vox Sanguinis, March 2021, Wiley

    Doctor Clive R Seed

  13. Endoscopies, blood‐borne viruses and blood donors: time to move on from precaution

    Article • Vox Sanguinis, October 2020, Wiley

    Doctor Clive R Seed

  14. Effect of HIV pre‐exposure prophylaxis (PrEP) on detection of early infection and its impact on the appropriate post‐PrEP deferral period

    Article • Vox Sanguinis, September 2020, Wiley

    Doctor Clive R Seed

  15. Severe acute respiratory syndrome coronavirus‐2: implications for blood safety and sufficiency

    Article • Vox Sanguinis, September 2020, Wiley

    Doctor Clive R Seed

  16. Modeling the West Nile virus transfusion transmission risk in a nonoutbreak country associated with traveling donors

    Article • Transfusion, August 2020, Wiley

    Doctor Clive R Seed

  17. A Systematic Review of Interventions Used to Increase Blood Donor Compliance with Deferral Criteria

    Article • Transfusion Medicine and Hemotherapy, July 2020, Karger Publishers

    Doctor Clive R Seed

  18. Attitudes and willingness to donate blood among gay and bisexual men in Australia

    Article • Transfusion, May 2020, Wiley

    Doctor Clive R Seed

  19. Blood donation amongst people who inject drugs in Australia: research supporting policy change

    Article • Vox Sanguinis, April 2020, Wiley

    Doctor Clive R Seed

  20. HIV residual risk in Canada under a three‐month deferral for men who have sex with men

    Article • Vox Sanguinis, November 2019, Wiley

    Doctor Clive R Seed

  21. Confirming transfusion‐transmitted viral infections in the molecular age: time to get back to the basic definition of infection for hemovigilance

    Article • Transfusion, November 2019, Wiley

    Doctor Clive R Seed

  22. Blood safety assessment of hepatitis A outbreak linked to frozen pomegranate arils: are foodborne outbreaks an emerging blood safety risk?

    Article • Transfusion, October 2019, Wiley

    Doctor Clive R Seed

  23. Excluding Occult Hepatitis B Infection before Assigning False-Positive Status to Non-Repeatable NAT Reactivity: Concerning Stolz et al. “Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Cou...

    Article • Transfusion Medicine and Hemotherapy, August 2019, Karger Publishers

    Doctor Clive R Seed

  24. Tattoos, blood‐borne viruses and blood donors: a blood donor cohort and risk assessment

    Article • Vox Sanguinis, August 2019, Wiley

    Doctor Clive R Seed

  25. Changing the deferral for men who have sex with men – an improved model to estimate HIV residual risk

    Article • Vox Sanguinis, August 2019, Wiley

    Doctor Clive R Seed

  26. Undetectable does not equal untransmittable for HIV and blood transfusion

    Article • Vox Sanguinis, May 2019, Wiley

    Doctor Clive R Seed

  27. No evidence for widespread Babesia microti transmission in Australia

    Article • Transfusion, May 2019, Wiley

    Doctor Clive R Seed

  28. International forum on Occult hepatitis B infection and transfusion safety

    Article • Vox Sanguinis, February 2019, Wiley

    Doctor Clive R Seed

  29. Modelling the risk of transfusion-transmitted syphilis: a reconsideration of blood donation testing strategies

    Article • Vox Sanguinis, December 2018, Wiley

    Doctor Clive R Seed

  30. Estimation of human T-lymphotropic virus incidence in blood donors from observed prevalence

    Article • Vox Sanguinis, October 2018, Wiley

    Doctor Clive R Seed

  31. Creutzfeldt-Jakob disease and blood transfusion safety

    Article • Vox Sanguinis, January 2018, Wiley

    Doctor Clive R Seed

  32. Emerging infectious disease outbreaks: estimating disease risk in Australian blood donors travelling overseas

    Article • Vox Sanguinis, October 2017, Wiley

    Doctor Clive R Seed

  33. Reconsideration of blood donation testing strategy for human T-cell lymphotropic virus in Australia

    Article • Vox Sanguinis, September 2017, Wiley

    Doctor Clive R Seed

  34. Value of retaining HBsAg donor screening where HBV NAT and anti-HBc donor screening apply

    Article • ISBT Science Series, September 2017, Wiley

    Doctor Clive R Seed

  35. Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment

    Article • Vox Sanguinis, August 2017, Wiley

    Doctor Clive R Seed

  36. HIV pre-exposure prophylaxis (PrEP) and blood donation

    Article • Vox Sanguinis, March 2017, Wiley

    Doctor Clive R Seed

  37. Hepatitis E virus seroepidemiology: a post-earthquake study among blood donors in Nepal

    Article • BMC Infectious Diseases, November 2016, Springer Science + Business Media

    Doctor Clive R Seed

  38. Refining the risk estimate for transfusion-transmission of occult hepatitis B virus

    Article • Vox Sanguinis, August 2016, Wiley

    Doctor Clive R Seed

  39. Re-evaluating the residual risk of transfusion-transmitted Ross River virus infection

    Article • Vox Sanguinis, January 2016, Wiley

    Doctor Clive R Seed

  40. Detection of emergent strains of West Nile virus with a blood screening assay

    Article • Transfusion, December 2015, Wiley

    Dr Yin Xiang Setoh, Doctor Clive R Seed

  41. Hepatitis E

    Article • Vox Sanguinis, July 2015, Wiley

    Doctor Clive R Seed

  42. The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries

    Article • Transfusion Medicine Reviews, July 2015, Elsevier

    Doctor Clive R Seed

  43. The residual risk of transfusion-transmitted cytomegalovirus infection associated with leucodepleted blood components

    Article • Vox Sanguinis, April 2015, Wiley

    Doctor Clive R Seed

  44. First reported case of transfusion‐transmitted Ross River virus infection

    Article • The Medical Journal of Australia, March 2015, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Doctor Clive R Seed

  45. Hepatitis E virus: do locally acquired infections in Australia necessitate laboratory testing in acute hepatitis patients with no overseas travel history?

    Article • Pathology, February 2015, Elsevier

    Doctor Clive R Seed

  46. Seroprevalence of Antibodies to Ross River and Barmah Forest Viruses: Possible Implications for Blood Transfusion Safety After Extreme Weather Events

    Article • EcoHealth, December 2014, Springer Science + Business Media

    Doctor Clive R Seed

  47. Hepatitis E Virus and Implications for Blood Supply Safety, Australia

    Article • Emerging Infectious Diseases, November 2014, Centers for Disease Control and Prevention (CDC)

    Doctor Clive R Seed

  48. Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme

    Article • Vox Sanguinis, September 2014, Wiley

    Doctor Clive R Seed

  49. A refined method for estimating the size of the potential blood donor pool in Australia

    Article • Transfusion, May 2014, Wiley

    Doctor Clive R Seed

  50. Understanding noncompliance with selective donor deferral criteria for high-risk behaviors in Australian blood donors

    Article • Transfusion, April 2014, Wiley

    Doctor Clive R Seed

  51. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection

    Article • Transfusion, March 2014, Wiley

    Doctor Clive R Seed

  52. Compliance with the current 12-month deferral for male-to-male sex in Australia

    Article • Vox Sanguinis, October 2013, Wiley

    Doctor Clive R Seed

  53. A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening

    Article • Vox Sanguinis, June 2013, Wiley

    Doctor Clive R Seed

  54. Implications of Dengue Outbreaks for Blood Supply, Australia

    Article • Emerging Infectious Diseases, May 2013, Centers for Disease Control and Prevention (CDC)

    Doctor Clive R Seed

  55. Trends in transfusion-transmissible infections among Australian blood donors from 2005 to 2010

    Article • Transfusion, March 2013, Wiley

    Doctor Clive R Seed

  56. Malaria antibody persistence correlates with duration of exposure

    Article • Vox Sanguinis, November 2012, Wiley

    Doctor Clive R Seed

  57. Two cases of asymptomatic HBV “vaccine breakthrough” infection detected in blood donors screened for HBV DNA

    Article • The Medical Journal of Australia, June 2012, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Doctor Clive R Seed

  58. Surveillance of Transfusion-Transmissible Infections

    Article • Transfusion Medicine Reviews, January 2012, Elsevier

    Doctor Clive R Seed

  59. Duration of Ross River viraemia in a mouse model - implications for transfusion transmission

    Article • Vox Sanguinis, September 2011, Wiley

    Doctor Clive R Seed

  60. Malaria antibody testing of Australian blood donors

    Article • Vox Sanguinis, January 2011, Wiley

    Doctor Clive R Seed

  61. No evidence of a significantly increased risk of transfusion-transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12-month deferral for men who have had sex with men (CME)

    Article • Transfusion, July 2010, Wiley

    Doctor Clive R Seed

  62. Can Blood Tranfusion Transmit Cancer? A Literature Review

    Article • Transfusion Medicine Reviews, July 2010, Elsevier

    Doctor Clive R Seed

  63. Assessing the safety and efficacy of a test-based, targeted donor screening strategy to minimize transfusion transmitted malaria

    Article • Vox Sanguinis, April 2010, Wiley

    Doctor Clive R Seed

  64. Two HBV DNA+/HBsAg− blood donors identified by HBV NAT in Shenzhen, China

    Article • Transfusion and Apheresis Science, August 2009, Elsevier

    Doctor Clive R Seed

  65. The risk of dengue transmission by blood during a 2004 outbreak in Cairns, Australia

    Article • Transfusion, July 2009, Wiley

    Doctor Clive R Seed

  66. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood

    Article • Transfusion, January 2009, Wiley

    Doctor Clive R Seed

  67. Comparison of the risk of viral infection between the living and nonliving musculoskeletal tissue donors in Australia

    Article • Transplant International, October 2008, Wiley

    Albert Farrugia, Doctor Clive R Seed

  68. Trends in Prevalence of Viral Infections in Australian Musculoskeletal Tissue Donors and Projections of Incidence and Residual Risk, 1993–2004

    Article • Transplantation, September 2008, Wolters Kluwer Health

    Albert Farrugia, Doctor Clive R Seed

  69. Emerging viral threats to the Australian blood supply

    Article • Australian and New Zealand Journal of Public Health, August 2008, Wiley

    Doctor Clive R Seed

  70. Estimating the risk of blood donation associated with HIV risk behaviours

    Article • Transfusion Medicine, February 2008, Wiley

    Doctor Clive R Seed

  71. Reply

    Article • Transfusion, December 2007, Wiley

    Albert Farrugia, Doctor Clive R Seed

  72. The Risk of HIV, HBV, HCV and HTLV Infection Among Musculoskeletal Tissue Donors in Australia

    Article • American Journal of Transplantation, December 2007, Wiley

    Albert Farrugia, Doctor Clive R Seed

  73. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA

    Article • Transfusion, October 2007, Wiley

    Doctor Clive R Seed

  74. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004

    Article • Transfusion, March 2007, Wiley

    Albert Farrugia, Doctor Clive R Seed

  75. Evidence for undetected malaria infection in non-immune Australian travellers not taking chemoprophylaxis

    Article • Acta Tropica, August 2006, Elsevier

    Doctor Clive R Seed

  76. Erratum

    Article • Transfusion Medicine Reviews, October 2005, Elsevier

    Doctor Clive R Seed

  77. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus

    Article • Internal Medicine Journal, October 2005, Wiley

    Doctor Clive R Seed

  78. The Current Status and Potential Role of Laboratory Testing to Prevent Transfusion-Transmitted Malaria

    Article • Transfusion Medicine Reviews, July 2005, Elsevier

    Doctor Clive R Seed

  79. International Forum: 1

    Article • Vox Sanguinis, May 2005, Wiley

    Doctor Clive R Seed

  80. The efficacy of a malarial antibody enzyme immunoassay for establishing the reinstatement status of blood donors potentially exposed to malaria

    Article • Vox Sanguinis, February 2005, Wiley

    Doctor Clive R Seed

  81. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests

    Article • Vox Sanguinis, July 2003, Wiley

    Doctor Clive R Seed

  82. Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays

    Article • Transfusion, February 2003, Wiley

    Doctor Clive R Seed

  83. Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies

    Article • Vox Sanguinis, January 2003, Wiley

    Doctor Clive R Seed

  84. Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies

    Article • Vox Sanguinis, July 2001, Wiley

    Doctor Clive R Seed